CRMD

Healthcare Biotechnology

CorMedix Inc.

$7.24

-0.10 -1.36% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 7, 2026, live at 1:34 PM ET	7.24

Key Stats

Market Cap

564.32M

Avg Volume

1.06M

P/E (TTM)

3.53

EPS

$2.05

52W High

$13.02

52W Low

$6.13

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

20.69

P/B Ratio

1.22

P/S Ratio

1.22

EV/EBITDA

1.75

EV/Revenue

0.99

PEG Ratio

5.21

Margins

Gross Margin 90.2%

Operating Margin 42.1%

Net Margin 40.5%

EBITDA Margin 56.8%

Growth & Returns

Revenue Growth (YoY)

156.5%

Earnings Growth (YoY)

6.7%

Earnings Growth (QoQ)

31.1%

Return on Equity

54.9%

Return on Assets

24.6%

Liquidity & Leverage

Current Ratio

2.56

Quick Ratio

2.23

Debt / Equity

0.32

Total Cash

256.69M

Total Debt

147.46M

About

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

cormedix.com